The above results showed that overexpression of SAMD1 could reduce anti‐B2GPI and ACA levels, shorten aPTT, and increase PLT, thereby reversing APS‐induced vascular injury to some extent. The gene discussed is SAMD1; the disease is autoimmune polyendocrinopathy.